Fulcrum Therapeutics Stock Forward View - Relative Strength Index
| FULC Stock | USD 11.00 0.73 6.22% |
Fulcrum Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Fulcrum Therapeutics stock prices and determine the direction of Fulcrum Therapeutics's future trends based on various well-known forecasting models. We suggest always using this module together with an analysis of Fulcrum Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, the relative strength index (RSI) of Fulcrum Therapeutics' share price is approaching 49. This usually indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Fulcrum Therapeutics, making its price go up or down. Momentum 49
Impartial
Oversold | Overbought |
Using Fulcrum Therapeutics hype-based prediction, you can estimate the value of Fulcrum Therapeutics from the perspective of Fulcrum Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Fulcrum Therapeutics after-hype prediction price | USD 10.99 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Fulcrum Therapeutics to cross-verify your projections. Fulcrum Therapeutics Additional Predictive Modules
Most predictive techniques to examine Fulcrum price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Fulcrum using various technical indicators. When you analyze Fulcrum charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 49.22 | 49.22 |
| Check Fulcrum Therapeutics Volatility | Backtest Fulcrum Therapeutics | Information Ratio |
Fulcrum Therapeutics Trading Date Momentum
| On February 22 2026 Fulcrum Therapeutics was traded for 11.00 at the closing time. The top price for the day was 11.89 and the lowest listed price was 10.95 . There was no trading activity during the period 0.0. Lack of trading volume on February 22, 2026 did not affect price variability. The overall trading delta against the current closing price is 5.36% . |
| Compare Fulcrum Therapeutics to competition |
Other Forecasting Options for Fulcrum Therapeutics
For every potential investor in Fulcrum, whether a beginner or expert, Fulcrum Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Fulcrum Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Fulcrum. Basic forecasting techniques help filter out the noise by identifying Fulcrum Therapeutics' price trends.Fulcrum Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Fulcrum Therapeutics stock to make a market-neutral strategy. Peer analysis of Fulcrum Therapeutics could also be used in its relative valuation, which is a method of valuing Fulcrum Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Fulcrum Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Fulcrum Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Fulcrum Therapeutics shares will generate the highest return on investment. By undertsting and applying Fulcrum Therapeutics stock market strength indicators, traders can identify Fulcrum Therapeutics entry and exit signals to maximize returns.
Fulcrum Therapeutics Risk Indicators
The analysis of Fulcrum Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Fulcrum Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting fulcrum stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.98 | |||
| Semi Deviation | 4.32 | |||
| Standard Deviation | 7.31 | |||
| Variance | 53.38 | |||
| Downside Variance | 19.99 | |||
| Semi Variance | 18.7 | |||
| Expected Short fall | (4.78) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Fulcrum Therapeutics
The number of cover stories for Fulcrum Therapeutics depends on current market conditions and Fulcrum Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Fulcrum Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Fulcrum Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Fulcrum Therapeutics Short Properties
Fulcrum Therapeutics' future price predictability will typically decrease when Fulcrum Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Fulcrum Therapeutics often depends not only on the future outlook of the potential Fulcrum Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Fulcrum Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 62 M | |
| Cash And Short Term Investments | 241 M |
Check out Historical Fundamental Analysis of Fulcrum Therapeutics to cross-verify your projections. For information on how to trade Fulcrum Stock refer to our How to Trade Fulcrum Stock guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Will Pharmaceuticals sector continue expanding? Could Fulcrum diversify its offerings? Factors like these will boost the valuation of Fulcrum Therapeutics. Market participants price Fulcrum higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Fulcrum Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Fulcrum Therapeutics is measured differently than its book value, which is the value of Fulcrum that is recorded on the company's balance sheet. Investors also form their own opinion of Fulcrum Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Fulcrum Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Fulcrum Therapeutics' market value can be influenced by many factors that don't directly affect Fulcrum Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fulcrum Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fulcrum Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Fulcrum Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.